Clinical Trials Browser

INDUSTRY × Has results × Capecitabine × Clear all

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

Breast Neoplasms

Breast Neoplasms

Adenocarcinoma Of Esophagus, Esophageal Neoplasms, Gallbladder Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Cholangiocarcinoma

Adenocarcinoma, Neoplasms, Stomach Neoplasms

Breast Neoplasms, Neoplasm Metastasis

Stomach Neoplasms

Breast Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Squamous Cell Carcinoma of Head and Neck

Triple Negative Breast Neoplasms

Adenocarcinoma, Neoplasms, Stomach Neoplasms

Breast Neoplasms, Neoplasm Metastasis

Locally Advanced and Metastatic Solid Tumors

Esophageal Neoplasms, Neoplasm Metastasis, Neoplasms

Adenocarcinoma Of Esophagus, Stomach Neoplasms

Esophageal Squamous Cell Carcinoma

Adenocarcinoma, Gastrointestinal Neoplasms, Neoplasm Metastasis

Pancreatic Neoplasms

Colorectal Neoplasms

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

Colorectal Neoplasms

Breast Neoplasms

Pancreatic Neoplasms

Triple Negative Breast Neoplasms

Pancreatic Neoplasms

Pancreatic Neoplasms

Breast Neoplasms

Stomach Neoplasms

Colorectal Neoplasms

Advanced Gastrointestinal Cancer

Brain Neoplasms, Breast Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Nasopharyngeal Neoplasms

Breast Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

Locally Advanced Rectal Cancer

Breast Neoplasms

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Stomach Neoplasms, Colorectal Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Stomach Neoplasms

Breast Neoplasms

Neoplasm Metastasis, Neoplasms

Breast Neoplasms

Brain Neoplasms, Breast Neoplasms, Triple Negative Breast Neoplasms

Parkinson Disease 4, Autosomal Dominant Lewy Body, Triple Negative Breast Neoplasms

Breast Neoplasms

Metastatic Gastric Adenocarcinoma

Breast Neoplasms

HER2+ Metastatic Breast Cancer (MBC)

Breast Neoplasms, Neoplasm Metastasis

Breast Neoplasms

Breast Neoplasms, Neoplasm Metastasis

Clinical Trials

KEYNOTE-585

DB-06

DS-8201a in Pre-treated HER2 Breast Cancer That Cannot be Surgically Removed or Has Spread [DESTINY-Breast02]

Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers

GLOW

A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)

A Study of Atezolizumab and Trastuzumab in Combination With Capecitabine and Oxaliplatin in Patients With HER2 Positive Locally Advanced Resectable Gastric Cancer of Adenocarcinoma of Gastroesophageal Junction

MK-7119-001

LEAP-009

IMpassion132

DisTinGuish

Trastuzumab Deruxtecan (DS-8201a) Versus Investigator's Choice for HER2-low Breast Cancer That Has Spread or Cannot be Surgically Removed [DESTINY-Breast04]

Study of Ociperlimab (BGB-A1217) in Combination With Tislelizumab in Advanced Solid Tumors

LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib

CheckMate649

A Study of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First Line Treatment in Participants With Advanced Esophageal Squamous Cell Carcinoma

A Study of IMU-131(HER-Vaxx) and Chemotherapy Compared to Chemotherapy Only in Patients With HER2 Positive Advanced Gastric Cancer

QUILT-3.060: NANT Pancreatic Cancer Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy

QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine

A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer

LYNK-003

RIGHT Choice

QUILT-3.080: NANT Pancreatic Cancer Vaccine

QUILT-3.067: NANT Triple Negative Breast Cancer (TNBC) Vaccine: Molecularly Informed Integrated Immunotherapy in Subjects With TNBC Who Have Progressed on or After Standard-of-care Therapy.

QUILT-3.039: NANT Pancreatic Cancer Vaccine: Combination Immunotherapy in Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy

QUILT-3.070:Pancreatic Cancer Vaccine: Subjects With Pancreatic Cancer Who Have Progressed on or After Standard-of-care Therapy

Study of Oral Vinorelbine Plus Capecitabine Versus Taxane-gemcitabine Combinations as 1st Line Chemotherapy in Metastatic Breast Cancer

A Study of SHR-1210 in Combination With Capecitabine + Oxaliplatin or Apatinib in Treatment of Advanced Gastric Cancer

A Study of BBI608 in Adult Patients With Advanced Colorectal Cancer

A Study of BBI608 in Combination With Standard Chemotherapies in Adult Patients With Advanced Gastrointestinal Cancer

HER2CLIMB

Keynote-122

Eribulin in Combination With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive Early Stage Breast Cancer

MK-3475-062

Study of Peposertib in Combination With Capecitabine and RT in Rectal Cancer

A Study to Characterize Colon Pathology in Patients With HER2 Amplified Breast Cancer Treated With Neratinib

A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive Cancers

KEYNOTE-059

ASCENT

Avelumab in First-Line Maintenance Gastric Cancer (JAVELIN Gastric 100)

Trial of Vinflunine Plus Capecitabine in Advanced Breast Cancer

STAR Cape+BKM120 MBC With Brain Met

KEYNOTE-119

Lapatinib +Capecitabine Treatment for Advanced Metastatic Breast Cancer in Women From China

RAINFALL

A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast Cancer

NALA

BOLERO-6

A Confirmation Study of Eribulin in Combination With Capecitabine

Novel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer